This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Reasons Why Church & Dwight (CHD) is Up 17% in 3 Months
by Zacks Equity Research
Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. Additionally, its focus on buyouts is encouraging.
Nordstorm Re-Opens Revamped San Juan Store in Puerto Rico
by Zacks Equity Research
Nordstorm (JWN) reopens its San Juan store in Puerto Rico ahead of the holiday season, in sync with its store expansion and remodeling initiatives.
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
by Zacks Equity Research
Zacks.com featured highlights include: Ralph Lauren, Estee Lauder, GMS, CytRx and T2 Biosystems
Here's Why Coty (COTY) Stock Crashes Despite Q1 Earnings Beat
by Zacks Equity Research
Coty's (COTY) earnings improve year over year and top estimates in Q1. However, revenues remain soft, owing to supply-chain hurdles and soft Consumer Beauty performance.
3 Reasons Why Estee Lauder (EL) is a Hot Investment Pick
by Zacks Equity Research
Estee Lauder???s (EL) strong online business and several strategic buyouts to enhance its portfolio bode well for the company. Also, it remains focused on enhancing travel retail business.
Bet on Rising P/E Investing With These 5 Top-Ranked Stocks
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Here's Why Helen of Troy is Set to Sustain Its Solid Show
by Zacks Equity Research
Helen of Troy (HELE) is benefitting from focus on Leadership Brands, robust digital efforts and Project Refuel program.
Estee Lauder (EL) Stock Up on Q1 Earnings Beat, Raised View
by Zacks Equity Research
Estee Lauder's (EL) Q1 performance continues to gain from growth in most brands and categories. However, performance in the Americas segment is dismal.
Estee Lauder (EL) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 15.57% and 1.35%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
Forget about the other 1,000 companies reporting this week. These are the must-watch stocks.
CLX, EL Q1 Earnings on Oct 31: Here are the Key Predictions
by Zacks Equity Research
Clorox (CLX) and Estee Lauder (EL) are slated to report first-quarter fiscal 2019 results on Oct 31.
What's in the Offing for Avon (AVP) This Earnings Season?
by Zacks Equity Research
Avon (AVP) is witnessing sales and earnings decline for the last few years on account of slowed Representatives growth. However, the company's Transformation plan remains encouraging.
Can Clorox (CLX) Retain its Earnings Beat Streak in Q1?
by Zacks Equity Research
Clorox (CLX) gains from its 2020 Strategy, Go Lean Strategy, enhancement of e-commerce business and disciplined capital allocation, which are likely to drive first-quarter fiscal 2019 results.
Should You Buy Estee Lauder (EL) Ahead of Earnings?
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Factors Likely to Influence Molson Coors' (TAP) Q3 Earnings
by Zacks Equity Research
Molson Coors (TAP) has a dismal top and bottom line trend. Also, it continues to battle input cost inflation. However, its restructuring plans to reduce costs and boost profitability are impressive.
Factors Likely to Influence Coca-Cola's (KO) Q3 Earnings
by Zacks Equity Research
Coca-Cola (KO) gains from the effective execution of strategies to evolve as a consumer-centric total beverage company.
Estee Lauder (EL) Q1 Earnings: Travel Retail to Stay Strong?
by Zacks Equity Research
Growth in travel retail business is a major driver for Estee Lauder (EL). Also, the company is likely to gain from buyouts of Too Faced and BECCA.
Estee Lauder (EL) Q1 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Colgate (CL) is progressing well with its Global Growth and Efficiency Program. However, it witnesses strained margins due to higher raw material and packaging costs.
Why the Earnings Surprise Streak Could Continue for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Consumer Beauty Unit Hits Coty, Luxury Offers Some Breather
by Zacks Equity Research
Coty's (COTY) Consumer Beauty category has been weak, while the Luxury and Professional Beauty segments have been performing impressively.
Ulta Beauty (ULTA) Up 19% in 3 Months on Strategic Efforts
by Zacks Equity Research
Ulta Beauty's (ULTA) robust store-expansion efforts, higher market share gains, sturdy e-commerce sales and salon operations is driving the stock's bullish run on the bourses.
The Zacks Analyst Blog Highlights: Chevron, Amgen, Thermo Fisher, Estee Lauder and Delta Air Lines
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chevron, Amgen, Thermo Fisher, Estee Lauder and Delta Air Lines
Top Stock Reports for Chevron, Amgen & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Chevron (CVX), Amgen (AMGN), and Thermo Fisher (TMO).
Avon Announces Long-Term Financial Targets & Growth Strategy
by Zacks Equity Research
Avon Products (AVP) announces long-term financial targets, backed by its new "Open Up Avon" strategy.